Alcaftadine (Lastacaft) 0.25% - H1 antihistamine, 1 drop each eye QD for age >2 years old
Ophthalmic Corticosteroids
In ophthalmology, no steroid is considered “safe", therefore patients given ocular steroids should be monitored by an ophthalmologist due to risk of increased intraocular pressure, infection, and cataracts
Preferable to use agents with low absorption through ocular surface
Loteprednol etabonate 0.2% (Alrex) - One drop into affected eyes QID
Indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
Adverse reactions include elevated intraocular pressure (1-2% of those treated for 28 days), which may be associated with optic nerve damage, posterior subcapsular cataracts, exacerbation of ocular viral and fungal infections
Notes Regarding Administration
Allow at least 5 minutes between instillation of different eye medications to decrease washout
Closing eyelids after drug instillation helps increase absorption into ocular tissues
Routine Allergic Conjunctivitis Medications
Ophthalmic Corticosteroids
Notes Regarding Administration
References